Department of Medicine, Box 800419, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Cell Microbiol. 2011 Jan;13(1):123-34. doi: 10.1111/j.1462-5822.2010.01525.x. Epub 2010 Oct 14.
Bacillus anthracis oedema toxin (ET) and Bordetella pertussis adenylate cyclase toxin (ACT) enter host cells and produce cAMP. To understand the cellular consequences, we exposed J774 cells to these toxins at ng ml(-1) (pM) concentrations, then followed cell number and changes in cell signalling pathways. Under these conditions, both toxins produce a concentration-dependent inhibition of cell proliferation without cytotoxicity. ET and ACT increase the proportion of cells in G(1) /G(0) and reduce S phase, such that a single addition of ET or ACT inhibits cell division for 3-6 days. Treatment with ET or ACT produces striking changes in proteins controlling cell cycle, including virtual elimination of phosphorylated ERK 1/2 and Cyclin D1 and increases in phospho-CREB and p27(Kip1) . Importantly, PD98059, a MEK inhibitor, elicits a comparable reduction in Cyclin D1 to that produced by the toxins and blocks proliferation. These data show that non-lethal concentrations of ET and ACT impose a prolonged block on the proliferation of J774 cells by impairment of the progression from G(1) /G(0) to S phase in a process involving cAMP-mediated increases in phospho-CREB and p27(Kip1) and reductions in phospho-ERK 1/2 and Cyclin D1. This phenomenon represents a new mechanism by which these toxins affect host cells.
炭疽杆菌水肿毒素 (ET) 和百日咳博德特氏菌腺苷酸环化酶毒素 (ACT) 进入宿主细胞并产生 cAMP。为了了解细胞后果,我们以 ng ml(-1) (pM) 的浓度将这些毒素暴露于 J774 细胞,然后跟踪细胞数量和细胞信号通路的变化。在这些条件下,两种毒素均产生浓度依赖性的细胞增殖抑制而无细胞毒性。ET 和 ACT 增加 G(1) /G(0) 期细胞的比例并减少 S 期,使得 ET 或 ACT 的单次添加可抑制细胞分裂 3-6 天。用 ET 或 ACT 处理会引起控制细胞周期的蛋白质发生明显变化,包括磷酸化 ERK 1/2 和 Cyclin D1 的几乎消除,以及磷酸化 CREB 和 p27(Kip1) 的增加。重要的是,MEK 抑制剂 PD98059 引起的 Cyclin D1 减少与毒素产生的减少相当,并阻止增殖。这些数据表明,非致死浓度的 ET 和 ACT 通过 cAMP 介导的磷酸化 CREB 和 p27(Kip1) 的增加以及磷酸化 ERK 1/2 和 Cyclin D1 的减少,损害从 G(1) /G(0) 到 S 期的进展,从而对 J774 细胞的增殖施加长期阻断。这种现象代表了这些毒素影响宿主细胞的新机制。